Monday, October 28, 2024
10:00AM – 11:00AM ET
Please note this virtual program is 10:00AM Eastern, 9:00AM Central, 8:00AM Mountain and 7:00AM Pacific.
FACULTY
Aparna Parikh, MD Associate Professor of Medicine, Harvard Medical School Director of the MGH Cancer Center’s Global Cancer Care Program Director of Colorectal Medical Oncology Medical Director Center for Young Adult Colorectal Cancer FASCO Massachusetts General Hospital Cancer Center Tucker Gosnell Center for Gastrointestinal Malignancies Termeer Center for Targeted Therapies Boston, MA |
PROGRAM OVERVIEW
These Grand Rounds presentations are designed to assist members of multidisciplinary oncology care teams at VA hospitals, including oncologists, pathologists, and nurse practitioners, so that they may better understand and implement molecular diagnostic approaches and biomarker-driven testing strategies in their veteran patients with cancer. The program places special emphasis on the role of NTRK gene fusion and TRK fusion testing, the implications of TRK pathway aberrations in cancer pathogenesis, and clinical trial data surrounding TRK inhibitors.
TARGET AUDIENCE
This activity is intended for VA oncologists, VA pathologists, and nurse practitioners involved in the diagnosis and treatment of cancer patients.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize the current and future methods to detect molecular alterations, including next-generation sequencing (NGS), and compare different molecular diagnostic approaches
- Implement appropriate biomarker-driven testing strategies in oncology practice
- Describe the role of NTRK gene fusion and the clinical implications of TRK-fusion testing in cancer treatment algorithms
- Evaluate the implications of TRK pathway aberrations in cancer pathogenesis and the efficacy and safety profiles of approved TRK inhibitors
- Demonstrate a multi-disciplinary approach to precision medicine by promoting collaboration among healthcare professionals in the integration of TRK inhibitors into treatment plans
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]